SCHEMBL27901104

SCHEMBL27901104

CC(C)N1CCNCC1(C(N)=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10463076 0.81 SOS1 (0.38) —
SCHEMBL757660 0.69 SOS1 (0.32) —
SCHEMBL12339300 0.66 SOS1 (0.33) —
SCHEMBL6743419 0.66 SOS1 (0.31) —
SCHEMBL27901103 0.66 CHRM5 (0.31) —
SCHEMBL28044288 0.66 — —
SCHEMBL17789639 0.65 SOS1 (0.45) —
Hydrochloric Acid SCHEMBL4591290 0.64 CHRM5 (0.30) —
SCHEMBL29070654 0.63 — —
SCHEMBL13735001 0.62 CHRM5 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103764658-A Compounds, their pharmaceutical compositions and their uses as IDH1 mutants inhibitors for treating cancers AGIOS PHARMACEUTICALS INC 2014-04-30 — — CN disclosed
CN-102827170-A Active treatment compositions and use method thereof ANGIE OSWALD PHARMACEUTICALS CO LTD 2012-12-19 — — CN disclosed
Send feedback